Home > Congressional Record > March 27, 2020 > Extensions of Remarks > Page E333

March 27, 2020 - Issue: Vol. 166, No. 61 — Daily Edition116th Congress (2019 - 2020) - 2nd Session

Entire Issue (PDF)Browse By Date

RECOGNIZING ARKANSAS CHILDREN'S RESEARCH INSTITUTE TREATMENT; Congressional Record Vol. 166, No. 61
(Extensions of Remarks - March 27, 2020)

Text available as:

Formatting necessary for an accurate reading of this text may be shown by tags (e.g., <DELETED> or <BOLD>) or may be missing from this TXT display. For complete and accurate display of this text, see the PDF.


[Extensions of Remarks]
[Page E333]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




      RECOGNIZING ARKANSAS CHILDREN'S RESEARCH INSTITUTE TREATMENT

                                 ______
                                 

                          HON. J. FRENCH HILL

                              of arkansas

                    in the house of representatives

                         Friday, March 27, 2020

  Mr. HILL of Arkansas. Madam Speaker, I rise today to recognize 
researchers at the Arkansas Children's Research Institute for their 
hard work in developing a treatment for peanut allergy in children.
  Recently, the FDA announced the approval of Palforzia, an oral immune 
therapy that gradually desensitizes children to peanut proteins.
  This therapy has the potential to greatly reduce allergy-related 
deaths in children, given that 2.5 percent of children suffer from 
peanut allergies.
  This treatment would not have been possible without the research of 
Dr. Stacie Jones and her team on oral immune therapy.
  They developed the methods used in the trials for this peanut allergy 
treatment.
  I am proud to have such a skilled team of experts in my district at 
Children's Hospital, where I served on the board of directors for 14 
years.

                          ____________________